Imagine a hospital's budget is like a rigid old pipe that can't handle a sudden flood of patients. This work creates a more flexible plumbing system for healthcare money, allowing funds to move where they are needed most during crises. It also helps decide which new medical gadgets are actually worth the cost before they hit the market.
Healthcare budgets are often too rigid to handle sudden shocks like pandemics or the rising costs of aging populations. This leads to inefficient resource use and slow adoption of new medical technologies.
A resilience index for hospital activity and a participatory tool for the early evaluation of new health technologies.
If you are a medical device manufacturer dealing with slow market entry and payer rejection — this project developed a participatory approach for early evaluation of new technologies that helps speed up the adoption phase.
If you are a private health insurer dealing with unpredictable costs during pandemics — this project developed a resilience index applied to data from 4 EU countries that helps predict and manage hospital activity shocks.
If you are a data analytics firm dealing with inefficient resource allocation in clinics — this project developed evidence on how information-based incentives improve care quality without needing extra cash.
Based on available project data, there is no specific pricing or implementation cost mentioned for the developed tools.
The project has already tested its resilience index across 4 EU countries, suggesting the methodology is scalable across different national health systems.
Based on available project data, specific licensing terms are not provided; the project focuses on policy recommendations and evidence production.
The project develops policy recommendations to help EU member states improve financial management and resource allocation rules.
The project runs from 2023-01-01 to 2026-12-31, meaning final recommendations and tools will be fully available by the end of 2026.
The consortium is heavily academic, consisting of 18 partners with 9 universities and 3 research institutes. There is a total absence of industry partners (0% ratio) and SMEs, indicating that the output is currently focused on policy and theoretical evidence rather than immediate commercial products.
Contact the Universita Degli Studi di Verona regarding the resilience index methodology.
Contact us to find out how to apply these resilience indices to your health-tech market entry strategy.
